Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome

被引:58
作者
Robyn, J
Lemery, S
McCoy, JP
Kubofcik, J
Kim, YJ
Pack, S
Nutman, TB
Dunbar, C
Klion, AD
机构
[1] NIAID, NIH, Lab Allerg Dis, Bethesda, MD 20892 USA
[2] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[3] NHLBI, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA
[4] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA
[5] NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA
关键词
hypereosinophilia; lineage; clonal; imatinib; fusion gene;
D O I
10.1111/j.1365-2141.2005.05863.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myeloproliferative hypereosinophilic syndrome (MHES) is a disorder characterised by male predominance, marked eosinophilia, splenomegaly, tissue fibrosis, elevated serum tryptase and the presence of the FIP1L1/PDGFRA fusion gene in peripheral blood mononuclear cells. The characteristic hypercellular bone marrow with dysplastic eosinophils and spindle-shaped mast cells suggest that multiple lineages may be involved in the clonal process. To determine which haematopoietic lineages are involved in MHES, we purified cells of specific lineages from patients with MHES and used nested reverse transcription polymerase chain reaction (RT-PCR), quantitative RT-PCR and fluorescence in situ hybridisation to analyse the purified cell populations for the presence of the fusion gene. The fusion gene was detected in eosinophils, neutrophils, mast cells, T cells, B cells and monocytes. These results suggest that the mutation arises in a pluripotential haematopoietic progenitor cell capable of giving rise to multiple lineages. The basis for the preferential expansion of cosinophils and mast cells remains unclear.
引用
收藏
页码:286 / 292
页数:7
相关论文
共 27 条
[1]   Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis [J].
Akin, C ;
Kirshenbaum, AS ;
Semere, T ;
Worobec, AS ;
Scott, LM ;
Metcalfe, DD .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :140-147
[2]   Multilineage hematopoietic involvement in systemic mastocytosis [J].
Akin, C .
LEUKEMIA RESEARCH, 2003, 27 (10) :877-878
[3]   The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia [J].
Cools, J ;
Quentmeier, H ;
Huntly, BJP ;
Marynen, P ;
Griffin, JD ;
Drexler, HG ;
Gilliland, DG .
BLOOD, 2004, 103 (07) :2802-2805
[4]   PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease [J].
Cools, J ;
Stover, EH ;
Boulton, CL ;
Gotlib, J ;
Legare, RD ;
Amaral, SM ;
Curley, DP ;
Duclos, N ;
Rowan, R ;
Kutok, JL ;
Lee, BH ;
Williams, IR ;
Coutre, SE ;
Stone, RM ;
DeAngelo, DJ ;
Marynen, P ;
Manley, PW ;
Meyer, T ;
Fabbro, D ;
Neuberg, D ;
Weisberg, E ;
Griffin, JD ;
Gilliland, DG .
CANCER CELL, 2003, 3 (05) :459-469
[5]   A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].
Cools, J ;
DeAngelo, DJ ;
Gotlib, J ;
Stover, EH ;
Legare, RD ;
Cortes, J ;
Kutok, J ;
Clark, J ;
Galinsky, I ;
Griffin, JD ;
Cross, NCP ;
Tefferi, A ;
Malone, J ;
Alam, R ;
Schrier, SL ;
Schmid, J ;
Rose, M ;
Vandenberghe, P ;
Verhoef, G ;
Boogaerts, M ;
Wlodarska, I ;
Kantarjian, H ;
Marynen, P ;
Coutre, SE ;
Stone, R ;
Gilliland, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214
[6]  
Fleiss JL., 1979, APPL PSYCHOL MEAS, V3, P537, DOI DOI 10.1177/014662167900300410
[7]   Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production [J].
Gessner, A ;
Mohrs, K ;
Mohrs, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :1063-1072
[8]   FIP1L1-PDGFRα in hypereosinophilic syndrome and mastocytosis [J].
Gilliland, G ;
Cools, J ;
Stover, EH ;
Wlodarska, I ;
Marynen, P .
HEMATOLOGY JOURNAL, 2004, 5 :S133-S137
[9]   The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia:: implications for diagnosis, classification, and management [J].
Gotlib, J ;
Cools, J ;
Malone, JM ;
Schrier, SL ;
Gilliland, DG ;
Coutré, SE .
BLOOD, 2004, 103 (08) :2879-2891
[10]   Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome [J].
Griffin, JH ;
Leung, J ;
Bruner, RJ ;
Caligiuri, MA ;
Briesewitz, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7830-7835